Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 27, 2025
No evidence of fluctuations in daily step count between infusions in people with multiple sclerosis treated with anti-CD20 monoclonal antibodiesValerie J Block, Kyra Henderson, Shane Poole, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 21, 2017
The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS studyMark S Freedman, Thomas P Leist, Giancarlo Comi, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2019
Validation of a consumer-grade activity monitor for continuous daily activity monitoring in individuals with multiple sclerosisValerie J Block, Chao Zhao, Jill A Hollenbach, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 26, 2021
Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosisBruce Ac Cree, Jeffrey A Cohen, Anthony T Reder, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2017
SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohortsRiley Bove, Tanuja Chitnis, Bruce Ac Cree, et al.
Multiple Sclerosis and Related Disorders|May 28, 2023
Effects of baseline age and disease duration on the efficacy and safety of siponimod in patients with active SPMS: Post hoc analyses from the EXPAND studyLe H Hua, Amit Bar-Or, Stanley L Cohan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 21, 2015
Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosisLudwig Kappos, Nicola De Stefano, Mark S Freedman, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 21, 2026
Closing the referral gap: The role of a quality improvement initiative to enhance pelvic health physical therapy referrals for persons with multiple sclerosis-related bladder symptomsIlana Winawer, Riley Bove, Jaeleene Wijangco, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2018
Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosisRiley Bove, Carolyn Bevan, Elizabeth Crabtree, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 8, 2022
Immune cell subset profiling in multiple sclerosis after fingolimod initiation and continued treatment: The FLUENT studyYang Mao-Draayer, Jeffrey A Cohen, Amit Bar-Or, et al.
Pageof 4